- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/60 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
Patent holdings for IPC class C07D 277/60
Total number of patents in this class: 190
10-year publication summary
|
13
|
21
|
14
|
10
|
9
|
10
|
7
|
9
|
8
|
6
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 875 |
7 |
| EyePoint Pharmaceuticals, Inc. | 52 |
7 |
| LG Chem, Ltd. | 17937 |
6 |
| Ligand Pharmaceuticals Incorporated | 168 |
6 |
| Piramal Enterprises Limited | 151 |
6 |
| Bristol-myers Squibb Company | 4748 |
5 |
| Boehringer Ingelheim International GmbH | 4483 |
5 |
| PGI Drug Discovery LLC | 32 |
5 |
| The Regents of the University of California | 20802 |
4 |
| Duke University | 3181 |
4 |
| Chaperone Therapeutics, Inc | 5 |
4 |
| Rohm and Haas Electronic Materials Korea Ltd. | 332 |
4 |
| Sunovion Pharmaceuticals Inc. | 244 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| CHDI Foundation, Inc. | 107 |
3 |
| Connexios Life Sciences Pvt. Ltd. | 12 |
3 |
| Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences | 15 |
3 |
| Vigonvita Life Sciences Co., Ltd. | 33 |
3 |
| Merck Sharp & Dohme LLC | 3736 |
3 |
| Eyepoint, Inc. | 49 |
3 |
| Other owners | 102 |